Get started
Author

Aravind Sosale

Observed names: A. R. Sosale, A. Sosale, ARAVIND R. SOSALE, Aravind R Sosale, Aravind R. Sosale, Aravind Ramachandra Sosale, Aravind, Sosale Ramachandra, AravindR Sosale, SR Aravind, Sosale Aravind Sosale, Sosale Ramachandra Aravind, Sr Aravind
Institution: Diacon Hospital
Observed institutions: Apollo Hospitals, The University of Texas at San Antonio Health Science Center, CARE Hospitals, Krishna Institute of Medical Sciences, Diacon Hospital, USV (India), Diabetes Care & Hormone Clinic, Jothydev's Diabetes and Research Center, M.V. Hospital for Diabetes and Diabetes Research Centre, Osmania Medical College
ORCID: 0000-0001-7631-8777
Observed ORCID: 0000-0001-7631-8777
OpenAlex ID: A5081657937
The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS)
2004 · S.M. Sadikot, A. Nigam, et al. · Diabetes Research and Clinical Practice · 201
State of the art paper The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
2013 · Rodolfo Guardado-Mendoza, Annamaria Prioletta, et al. · Archives of Medical Science · 153
PDF
Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial
2020 · Mohammed K. Ali, Lydia Chwastiak, et al. · JAMA · 148
PDF
Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India
2014 · Aravind Sosale, KM Prasanna Kumar, et al. · Indian Journal of Endocrinology and Metabolism · 90
Medios– An offline, smartphone-based artificial intelligence algorithm for the diagnosis of diabetic retinopathy
2020 · Bhavana Sosale, AravindR Sosale, et al. · Indian Journal of Ophthalmology · 75
The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS)
2004 · S.M. Sadikot, A. Nigam, et al. · Diabetes Research and Clinical Practice · 68
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
2015 · Sosale Aravind Sosale, Banshi Saboo, et al. · Diabetes Metabolic Syndrome and Obesity · 66
PDF
Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data
2021 · Arjun Krishnakumar, Ritika Verma, et al. · Journal of Medical Internet Research · 64
PDF
Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy
2020 · Viswanathan Mohan, Ambrish Mithal, et al. · Drug Design Development and Therapy · 57
PDF
A multicentre, multinational, randomized, placebo‐controlled, double‐blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin ( LC15 ‐0444) in patients with type 2 diabetes
2012 · S. J. Yang, K. W. Min, et al. · Diabetes Obesity and Metabolism · 52
Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
2021 · Aravind Sosale, Bhavana Sosale, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 48
PDF
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
2013 · E. J. Rhee, W. Y. Lee, et al. · Diabetes Obesity and Metabolism · 44
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial
2021 · Lee-Ling Lim, Eric S. H. Lau, et al. · JAMA Network Open · 38
PDF
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study)
2025 · Viswanathan Mohan, Shashank Joshi, et al. · Diabetes Therapy · 33
PDF
Management of metabolic dysfunction–associated steatotic liver disease ( MASLD )—An expert consensus statement from Indian diabetologists' perspective
2025 · Abdul Hamid Zargar, Anil Bhansali, et al. · Diabetes Obesity and Metabolism · 26
PDF
Comparing the ADA 1997 and the WHO 1999 criteria: Prevalence of Diabetes in India Study
2004 · S.M. Sadikot, A. Nigam, et al. · Diabetes Research and Clinical Practice · 26
Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia
2021 · Jothydev Kesavadev, Anoop Misra, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 24
Cost-Effectiveness of a Collaborative Care Model Among Patients With Type 2 Diabetes and Depression in India
2022 · Karl M.F. Emmert-Fees, Michael Laxy, et al. · Diabetes Care · 17
Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program
2022 · Lee-Ling Lim, Eric S.H. Lau, et al. · The Lancet Regional Health - Western Pacific · 16
PDF
RSSDI consensus recommendations on insulin therapy in the management of diabetes
2019 · Expert panel (extended), R. Chawla, et al. · International Journal of Diabetes in Developing Countries · 16
Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries
2022 · Johnny T. K. Cheung, Eric Lau, et al. · BMC Medicine · 15
PDF
RSSDI clinical practice recommendations for management of In-hospital hyperglycaemia—2016
2016 · V. Panikar, A. Sosale, et al. · International Journal of Diabetes in Developing Countries · 15
Postprandial Glucose: A Variable in Continuum
2025 · Shashank Joshi, Jothydev Kesavadev, et al. · Clinical Medicine Insights Endocrinology and Diabetes · 12
Screening for diabetic retinopathy—is the use of artificial intelligence and cost-effective fundus imaging the answer?
2019 · Aravind R. Sosale · International Journal of Diabetes in Developing Countries · 12
PDF
Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes
2016 · Bhavana Sosale, Aravind Sosale, et al. · Diabetes Therapy · 12
PDF
Works count: 60
Citation count: 1,431
H-index: 17
I10-index: 27
Year
Topic
Type